Alumis Inc. Share Price
NASDAQ: ALMS | Small CapAlumis Inc. Stock Performance
Alumis Inc. Share Price Today
As of 31 October 2026, Alumis Inc.'s share price is $6.74. The stock opened at $6.87, compared to its previous close of $6.89. During today's trading session, Alumis Inc.'s share price traded between $6.46 and $6.87, with an average price of $6.67. Over the past 52 weeks, the stock has recorded a high of $31.30 and a low of $4.40. In terms of performance, Alumis Inc.'s share price has declined by 72.69% over the last six months and is up 42.39% on a year-on-year basis.
Alumis Inc. Share Price Chart
Alumis Inc. Quarterly Profit & Loss
All figures in USD
Alumis Inc. Annual Profit & Loss
All figures in USD
About Alumis Inc.
Alumis Inc is a clinical-stage biopharmaceutical company with an initial focus on developing its two Tyrosine Kinase 2 ("TYK2") inhibitors: envudeucitinib ("envu"), an allosteric TYK2 inhibitor for the treatment of PsO and SLE; and A-005, a central nervous system ("CNS") penetrant allosteric TYK2 inhibitor, to offer the therapeutic benefit of TYK2 inhibition within the CNS for a broad range of neuroinflammatory and neurodegenerative diseases.
Alumis Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $7.36 | $6.73 | -9.12% |
Sep 2026 | $9.92 | $7.41 | -68.08% |
Aug 2026 | $27.25 | $23.20 | -17.78% |
Jul 2026 | $27.65 | $28.21 | +0.36% |
Jun 2026 | $20.94 | $28.11 | +30.17% |
May 2026 | $25.06 | $21.59 | -12.43% |
Apr 2026 | $23.14 | $24.66 | +11.94% |
Mar 2026 | $29.00 | $22.03 | -25.70% |
Feb 2026 | $24.48 | $29.65 | +20.97% |
Jan 2026 | $9.49 | $24.51 | +151.38% |
Dec 2025 | $7.67 | $9.75 | +27.04% |
Nov 2025 | $4.70 | $7.67 | +62.26% |